MicroRNA: A Signature for Cancer Diagnostics

  • Siddiqua A
  • Kousar S
  • Jamil A
  • et al.
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Various tools and techniques are being used for the diagnosis of cancer, but not a sole technique provides powerful result at the very early stages of cancer. This provides the need for type of tools which could detect cancer at early stages so that survival rate could be augmented. There are various diagnostic ways to identify cancer, but in each case, there are always circumstances to compromise on the sensitivity. In this framework, a new and more advanced approach of diagnosis for cancer is microRNA (miRNA). miRNAs are conserved regions among humans and animals, and their synthesis takes place in the nucleus and cytoplasm. There are several types of microRNAs that could be upregulated and downregulated in various cancers. A cancer cell could be identified by measurement of the expression pattern of miRNA. By examining the expression level for different types of cancers, miRNA can be used as biomarker for early detection of cancer in human beings.

Cite

CITATION STYLE

APA

Siddiqua, A., Kousar, S., Jamil, A., Tabassum, R., Mehmood, T., & Shafiq, N. (2020). MicroRNA: A Signature for Cancer Diagnostics. In Current Cancer Treatment. IntechOpen. https://doi.org/10.5772/intechopen.90063

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free